4.8 Article

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

Journal

IMMUNITY
Volume 45, Issue 2, Pages 374-388

Publisher

CELL PRESS
DOI: 10.1016/j.immuni.2016.07.009

Keywords

-

Categories

Funding

  1. CCSG [P30CA047904]
  2. Sidney Kimmel Foundation for Cancer Research [SKF-015-039]
  3. NIH [1S10OD016236-01]
  4. NIH (Head and Neck Cancer SPORE) [P50 CA097190]
  5. NIH (Skin Cancer SPORE [developmental research award]) [P50CA121973]

Ask authors/readers for more resources

Although tumor-specific T cells recognize cancer cells, they are often rendered dysfunctional due to an immunosuppressive microenvironment. Here we showed that T cells demonstrated persistent loss of mitochondrial function and mass when infiltrating murine and human tumors, an effect specific to the tumor microenvironment and not merely caused by activation. Tumor-infiltrating T cells showed a progressive loss of PPAR-gamma coactivator 1 alpha (PGC1 alpha), which programs mitochondrial biogenesis, induced by chronic Akt signaling in tumor-specific T cells. Reprogramming tumor-specific T cells through enforced expression of PGC1 alpha resulted in superior intratumoral metabolic and effector function. Our data support a model in which signals in the tumor microenvironment repress T cell oxidative metabolism, resulting in effector cells with metabolic needs that cannot be met. Our studies also suggest that modulation or reprogramming of the altered metabolism of tumor-infiltrating T cells might represent a potential strategy to reinvigorate dysfunctional T cells for cancer treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available